Over-the-counter race hots up as Cann Group prepares to recruit patients for sleep disturbance trial by Steve Jones February 16, 2022February 16, 2022 Cann Group is preparing to recruit patients for a phase 3 clinical trial as it continues […]
Medlab signs deal to promote Cann Group’s Satipharm product to doctors by Steve Jones February 1, 2022February 1, 2022
Althea bets on dual strategy as CEO predicts big pharma will come knocking ‘sooner than we thought’ by Steve Jones September 23, 2021September 23, 2021
Cann Group COO: ‘we need to put our big boy pants on and adopt a pharmaceutical mindset’ by Steve Jones February 25, 2021February 25, 2021
Major doubts remain as industry reacts to CBD down scheduling by Steve Jones September 10, 2020September 14, 2020
